<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">F1000Res</journal-id>
<journal-id journal-id-type="iso-abbrev">F1000Res</journal-id>
<journal-id journal-id-type="pmc">F1000Research</journal-id>
<journal-title-group>
<journal-title>F1000Research</journal-title>
</journal-title-group>
<issn pub-type="epub">2046-1402</issn>
<publisher>
<publisher-name>F1000Research</publisher-name>
<publisher-loc>London, UK</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27239287</article-id>
<article-id pub-id-type="pmc">4870991</article-id>
<article-id pub-id-type="doi">10.12688/f1000research.8214.1</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
<subj-group>
<subject>Articles</subject>
<subj-group>
<subject>Cognitive Neurology &amp; Dementia</subject>
</subj-group>
<subj-group>
<subject>Control of Gene Expression</subject>
</subj-group>
<subj-group>
<subject>Developmental &amp; Pediatric Neurology</subject>
</subj-group>
<subj-group>
<subject>Epilepsy</subject>
</subj-group>
<subj-group>
<subject>Medical Genetics</subject>
</subj-group>
<subj-group>
<subject>Multiple Sclerosis &amp; Related Disorders</subject>
</subj-group>
<subj-group>
<subject>Neurobiology of Disease &amp; Regeneration</subject>
</subj-group>
<subj-group>
<subject>Neurodevelopment</subject>
</subj-group>
<subj-group>
<subject>Neurogenetics</subject>
</subj-group>
<subj-group>
<subject>Neuronal Signaling Mechanisms</subject>
</subj-group>
<subj-group>
<subject>Neurorehabilitation &amp; CNS Trauma</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Network science for the identification of novel therapeutic targets in epilepsy</article-title>
<fn-group content-type="pub-status">
<fn>
<p>[version 1; referees: 2 approved]</p>
</fn>
</fn-group>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Scott</surname>
<given-names>Rod C.</given-names>
</name>
<xref ref-type="corresp" rid="c1">a</xref>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<aff id="a1">
<label>1</label>Department of Neurological Sciences, University of Vermont, Burlington, VT, USA</aff>
<aff id="a2">
<label>2</label>Neurosciences Unit, UCL Institute of Child Health, London, UK</aff>
</contrib-group>
<author-notes>
<corresp id="c1">
<label>a</label>
<email xlink:href="mailto:rodney.scott@med.uvm.edu">rodney.scott@med.uvm.edu</email>
</corresp>
<fn fn-type="COI-statement">
<p>
<bold>Competing interests: </bold>The author declares that he has no competing interests.</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>16</day>
<month>5</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="collection">
<year>2016</year>
</pub-date>
<volume>5</volume>
<elocation-id>F1000 Faculty Rev-893</elocation-id>
<history>
<date date-type="accepted">
<day>11</day>
<month>5</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright: © 2016 Scott RC</copyright-statement>
<copyright-year>2016</copyright-year>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<license-p>This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="f1000research-5-8835.pdf" xlink:type="simple"></self-uri>
<abstract>
<p>The quality of life of children with epilepsy is a function of seizures and associated cognitive and behavioral comorbidities. Current treatments are not successful at stopping seizures in approximately 30% of patients despite the introduction of multiple new antiepileptic drugs over the last decade. In addition, modification of seizures has only a modest impact on the comorbidities. Therefore, novel approaches to identify therapeutic targets that improve seizures and comorbidities are urgently required. The potential of network science as applied to genetic, local neural network, and global brain data is reviewed. Several examples of possible new therapeutic approaches defined using novel network tools are highlighted. Further study to translate the findings into clinical practice is now required.</p>
</abstract>
<kwd-group kwd-group-type="author">
<kwd>epilepsy</kwd>
<kwd>therapeutic targets</kwd>
<kwd>network science</kwd>
</kwd-group>
<funding-group>
<funding-statement>This work was supported by National Institutes of Health grant 1R01NS074689 to RS.</funding-statement>
</funding-group>
</article-meta>
<notes>
<sec sec-type="editor-note">
<title>Editorial Note on the Review Process</title>
<p>
<ext-link ext-link-type="uri" xlink:href="http://f1000research.com/channels/f1000-faculty-reviews/about-this-channel">F1000 Faculty Reviews</ext-link> are commissioned from members of the prestigious
<ext-link ext-link-type="uri" xlink:href="http://f1000.com/prime/thefaculty">F1000 Faculty</ext-link> and are edited as a service to readers. In order to make these reviews as comprehensive and accessible as possible, the referees provide input before publication and only the final, revised version is published. The referees who approved the final version are listed with their names and affiliations but without their reports on earlier versions (any comments will already have been addressed in the published version).</p>
<p>The referees who approved this article are: </p>
<list list-content="reviewer-list" list-type="simple">
<list-item>
<p>
<named-content content-type="reviewer-name">Guillermo J Ortega</named-content>, Neurosurgery, Hospital Universitario la Princesa, Madrid, Spain
<fn fn-type="COI-statement"><p>No competing interests were disclosed.</p></fn>
</p>
</list-item>
<list-item>
<p>
<named-content content-type="reviewer-name">Ancor Sanz-García</named-content>, Hospital Universitario la Princesa, Madrid, Spain
<fn fn-type="COI-statement"><p>No competing interests were disclosed.</p></fn>
</p>
</list-item>
<list-item>
<p>
<named-content content-type="reviewer-name">Jerome Engel Jr</named-content>, Department of Neurology, David Geffen School of Medicine at University of California, Los Angeles, Los Angeles, CA, 90095-1769, USA
<fn fn-type="COI-statement"><p>No competing interests were disclosed.</p></fn>
</p>
</list-item>
</list>
</sec>
</notes>
</front>
<body>
<sec sec-type="intro">
<title>Introduction</title>
<p>Children with epilepsy have seizures that are frequently associated with cognitive and behavioral impairments
<sup><xref ref-type="bibr" rid="ref-1">1</xref></sup>. In combination, these factors negatively impact quality of life
<sup><xref ref-type="bibr" rid="ref-2">2</xref></sup> and greatly diminish the ability of children with epilepsy to develop into successful adults. It is therefore critical that treatments aimed at modifying adverse outcomes are developed. Current therapies are largely targeted toward seizures and include antiepileptic drugs and dietary and surgical therapies. Although these therapies are effective in the treatment of seizures, approximately 30% of patients continue to have seizures despite maximal therapy
<sup><xref ref-type="bibr" rid="ref-3">3</xref></sup>. Specific therapies for behavioral difficulties include stimulants
<sup><xref ref-type="bibr" rid="ref-4">4</xref>,
<xref ref-type="bibr" rid="ref-5">5</xref></sup>, antipsychotics
<sup><xref ref-type="bibr" rid="ref-6">6</xref>,
<xref ref-type="bibr" rid="ref-7">7</xref></sup>, and antidepressants
<sup><xref ref-type="bibr" rid="ref-6">6</xref>,
<xref ref-type="bibr" rid="ref-7">7</xref></sup>. Therapies for learning impairments are largely educational. In all of these cases, the therapy targets symptoms without modifying the brain disorder responsible for the seizures and the associated morbidities. In order to develop new therapies, it is important that mechanisms of the underlying brain disorders are understood so that therapies can be targeted towards modifying those abnormalities and thereby improve outcomes.</p>
<p>The mechanisms underpinning adverse outcomes can be studied at a variety of levels including the level of genes, receptors, cell signaling pathways, and networks. Network science is providing new ways of understanding disease mechanisms and could lead to novel therapies targeted
<italic>directly</italic> at modifying network abnormalities underlying seizures and comorbidities, irrespective of the genetic or cell signaling abnormalities
<sup><xref ref-type="bibr" rid="ref-8">8</xref></sup> (
<xref ref-type="fig" rid="f1">Figure 1</xref>). This review will explore the potential of network science to contribute to the identification of novel therapeutic targets.</p>
<fig fig-type="figure" id="f1" orientation="portrait" position="float">
<label>Figure 1. </label>
<caption>
<title>Cartoon representing healthy and diseased networks.</title>
<p>Each node in the network could represent a gene, transcriptional module, single neuron, or brain region. The lines between the nodes represent relevant interactions between the nodes. Conceptually, the structure of the network is different in disease states compared to controls. In this example, the diseased network is over-connected (e.g. hypersynchrony in an epileptic brain). Targeting the network directly using drugs, brain stimulation, cell therapy, or transcranial magnetic stimulation approaches could modify the diseased network in order to allow more normal function. It remains unknown whether restoration of networks to normal (left network post-therapy) or modification to a network with similar phenotype to normal (right network post-therapy) is required. Understanding of these system-level mechanisms could lead to new treatments or optimization of currently used clinical tools, such as deep brain stimulation.</p>
</caption>
<graphic xlink:href="f1000research-5-8835-g0000"></graphic>
</fig>
</sec>
<sec>
<title>Understanding disease mechanisms at network levels</title>
<p>Disease mechanisms in the context of epilepsy can be conceptualized in at least two ways. The first is encapsulated in the epileptic encephalopathy hypothesis, which states that epileptic activity causes cognitive and behavioral impairments over and above those expected for the underlying etiology
<sup><xref ref-type="bibr" rid="ref-9">9</xref></sup>. In this circumstance, it can be argued that epileptic activity itself modifies neural networks in a way that no longer supports normal cognitive and behavioral function. The therapeutic implication is that treatment of seizures and interictal discharges will positively modify adverse outcomes. Despite many years of trying to improve cognitive and behavioral outcomes by targeting seizures, the positive impacts are rather modest
<sup><xref ref-type="bibr" rid="ref-1">1</xref>,
<xref ref-type="bibr" rid="ref-10">10</xref>,
<xref ref-type="bibr" rid="ref-11">11</xref></sup>. A common suggestion is that the treatment of seizures prevents any further decline in abilities. If correct, this suggests that alternative approaches to
<italic>improving</italic> outcomes are required.</p>
<p>The second concept places etiology in the forefront. In this view, patients with epilepsy all have an underlying etiology (even if it is unrecognized) and this is directly responsible for the neural network disruptions that lead to the symptoms of seizures and adverse cognitive and behavioral outcomes. It remains possible that seizures also make a contribution to the modification of networks, although it is difficult to clearly identify the magnitude of the contribution
<sup><xref ref-type="bibr" rid="ref-12">12</xref>,
<xref ref-type="bibr" rid="ref-13">13</xref></sup>. However, if etiology is the major contributor, then treatment of seizures is unlikely to have major positive impact, as observed in clinical practice. If seizures and cognitive/behavioral impairments are primarily a function of etiology, then disease-modifying therapies would be expected to improve all of the symptoms. Although this is an area receiving increasing attention, no such therapies are yet available in clinical practice.</p>
<p>The application of network science to these issues is gaining popularity
<sup><xref ref-type="bibr" rid="ref-8">8</xref></sup>. Network science is a mixture of graph theory, dynamical systems theory, and ideas from statistical mechanics
<sup><xref ref-type="bibr" rid="ref-8">8</xref></sup>. These tools can be applied to genetic, electrophysiological, and magnetic resonance data. The appropriate application of network science to epilepsy requires an interdisciplinary approach involving clinicians, translational neuroscientists, computer scientists, and mathematicians. Examples of novel insights that are arising from these interdisciplinary collaborations are discussed below.</p>
</sec>
<sec>
<title>Gene regulation networks</title>
<p>Genetic approaches have made significant contributions to the understanding of neurological disorders associated with seizures
<sup><xref ref-type="bibr" rid="ref-14">14</xref>–
<xref ref-type="bibr" rid="ref-17">17</xref></sup>. The hope is that gene replacement therapy may restore function, as in an animal model of Rett syndrome
<sup><xref ref-type="bibr" rid="ref-18">18</xref></sup>. This approach relates to single gene disorders, and the list of genes associated with epilepsies is rapidly growing
<sup><xref ref-type="bibr" rid="ref-17">17</xref>,
<xref ref-type="bibr" rid="ref-19">19</xref></sup>. Although it may be possible to replace the identified genes, many abnormalities are extremely rare, raising an important concern about the practical use of such approaches. An alternative approach is to use systems genetics to characterize the genetic regulation of pathophysiological pathways. This approach has previously been used to explore the pathophysiology of type 1 diabetes
<sup><xref ref-type="bibr" rid="ref-20">20</xref></sup>, autism
<sup><xref ref-type="bibr" rid="ref-21">21</xref>,
<xref ref-type="bibr" rid="ref-22">22</xref></sup>, febrile convulsions
<sup><xref ref-type="bibr" rid="ref-23">23</xref>–
<xref ref-type="bibr" rid="ref-25">25</xref></sup>, and the latter’s association with mesial temporal lobe epilepsy
<sup><xref ref-type="bibr" rid="ref-24">24</xref></sup>. An example of how systems genetics could identify a therapeutic target in epilepsy comes from a study of temporal lobe epilepsy
<sup><xref ref-type="bibr" rid="ref-26">26</xref></sup>. Johnson
<italic>et al</italic>. evaluated gene expression networks in post-surgical hippocampal tissue from patients with temporal lobe epilepsy. They identified a specialized, highly expressed transcriptional module encoding proconvulsive cytokine and Toll-like receptor signaling genes. Sestrin 3 positively regulates this module in macrophages, microglia, and neurons. This finding is also present in pilocarpine-exposed mice, which demonstrated pilocarpine-induced status epilepticus with subsequent temporal lobe epilepsy, giving further credibility to the clinical finding. Importantly, knockdown of Sestrin 3 in zebrafish attenuates chemically induced behavioral seizures. Therefore, it is possible that modulation of Sestrin 3 could modulate seizures in humans. It is unlikely that this target would have been identified without the mathematical approaches inherent in systems genetics. This study used tissue from epilepsy surgery, was carried out in adults, and targeted an etiology common in adults. However, the pathophysiological processes leading to mesial temporal sclerosis (MTS) frequently occur during development. Children with epilepsies frequently have malformations of cortical development, and similar approaches could be applied to this surgical tissue and have potential to identify other novel therapeutic targets. Modification of genetic signaling can be achieved with small interfering RNA (siRNA) and microRNA (miRNA) approaches. Identification of specific genes or regulatory gene networks could provide critical targets for these approaches that are already being tested in the clinical domain
<sup><xref ref-type="bibr" rid="ref-27">27</xref></sup>. These approaches can also be applied to epigenetic data and could provide important insights in that domain as well.</p>
</sec>
<sec>
<title>Local neural networks</title>
<p>Another level at which network approaches may identify therapeutic targets is at the level of local neuronal networks. This requires the identification of system-level mechanisms at the level of changes in neural circuitry that directly impair the ability of that circuit to support cognitive behavior. Information processing in a neural system is a function of the rate of firing of neurons (rate coding)
<sup><xref ref-type="bibr" rid="ref-28">28</xref>–
<xref ref-type="bibr" rid="ref-32">32</xref></sup>, the precise timing of action potential firing with respect to oscillatory activity (temporal coding)
<sup><xref ref-type="bibr" rid="ref-33">33</xref>,
<xref ref-type="bibr" rid="ref-34">34</xref></sup>, and joint activation of ensembles of neurons (population coding)
<sup><xref ref-type="bibr" rid="ref-35">35</xref>–
<xref ref-type="bibr" rid="ref-38">38</xref></sup>. It is known that each of these components of information processing can be abnormal in a variety of animal models of epilepsies. Rate coding as described by hippocampal place cells is disrupted following early life seizures and in the context of MTS
<sup><xref ref-type="bibr" rid="ref-39">39</xref>–
<xref ref-type="bibr" rid="ref-42">42</xref></sup>. The spatial fidelity of these cells is reduced and this is consistent with the abnormalities in spatial cognition identified in these models
<sup><xref ref-type="bibr" rid="ref-41">41</xref>,
<xref ref-type="bibr" rid="ref-43">43</xref>–
<xref ref-type="bibr" rid="ref-45">45</xref></sup>. Temporal and population coding have also been evaluated in models of MTS and found to be abnormal
<sup><xref ref-type="bibr" rid="ref-36">36</xref>,
<xref ref-type="bibr" rid="ref-39">39</xref></sup>. For example, excessive synchrony of CA1 pyramidal cell firing predicts poor performance in a spatial alternation task, suggesting that the organization of neuronal firing within a neural population is important for behavior
<sup><xref ref-type="bibr" rid="ref-36">36</xref></sup>. It remains uncertain whether this excessive synchrony is important for seizure generation, but modulation of this synchrony could both reduce seizures and improve cognition.</p>
<p>Many of the epilepsy models described above have associated structural abnormalities. Remarkably, cognitive outcomes can be improved with environmental enrichment and overtraining strategies, even in the context of the structural brain abnormalities
<sup><xref ref-type="bibr" rid="ref-46">46</xref></sup>, suggesting that structure-function relationships are not fixed. This could be exploited for therapeutic advantage if the network-level changes associated with these improvements could be identified. This remains an area of active research. However, some system-level interventions have been shown to improve outcomes in epilepsy. In humans, stimulation devices are known to reduce seizures and there is some evidence that stimulation of the entorhinal cortex can improve cognition
<sup><xref ref-type="bibr" rid="ref-47">47</xref></sup>. A detailed understanding of how networks need to be modified to improve outcomes would allow optimization of these tools. Electrical stimulation has the potential downside of activating all cell types, which may limit the possibility of more subtly altering neuronal interactions. In the future, optogenetic stimulation may allow more precise modulation of neural network behavior by activating only certain cell types.</p>
<p>Interneurons are critical for the organization of pyramidal cells
<sup><xref ref-type="bibr" rid="ref-48">48</xref></sup> and therefore may represent a cell target in epilepsy. Implantation of interneuron precursors into animal models of MTS reduces seizures
<sup><xref ref-type="bibr" rid="ref-49">49</xref>–
<xref ref-type="bibr" rid="ref-51">51</xref></sup> and, at least in some experiments, improves cognitive outcomes
<sup><xref ref-type="bibr" rid="ref-49">49</xref></sup>. In addition, optogenetic stimulation of interneurons using a closed loop system also reduces seizures
<sup><xref ref-type="bibr" rid="ref-52">52</xref></sup>. The system-level mechanisms underlying the improvements have not yet been explored in these models, but such studies could ultimately provide essential information for optimizing parameters and maximizing outcomes.</p>
<p>Although stimulation approaches are the most obvious application of the sort of system-level information described above, drug interventions may also be possible. For example, adrenocorticotropic hormone (ACTH) administration to rodents exposed to early life seizures improves attentional outcomes despite having no effect on the seizures
<sup><xref ref-type="bibr" rid="ref-53">53</xref></sup>. This suggests that ACTH is modulating information processing in a way that is currently unknown but deserves future study. The implication for the treatment of patients is that medications that do not influence seizures but improve cognitive outcomes may be beneficial. Therefore, outcome measures for clinical trials may need to include cognitive outcomes, such as in the UKISS trial of infantile spasms
<sup><xref ref-type="bibr" rid="ref-54">54</xref></sup>, and may even have to be designed to have cognition as the main outcome measure. Another speculative drug approach is the use of Designer Receptors Exclusively Activated by Designer Drugs (DREADDS)
<sup><xref ref-type="bibr" rid="ref-52">52</xref></sup>. This approach may also allow targeting of certain cell types within a network in order to modify the population activity of that network.</p>
</sec>
<sec>
<title>Global networks</title>
<p>The study of global networks within the context of epilepsy has used magnetic resonance, electroencephalography, and magnetoencephalography approaches. Although there is a wealth of data on the phenomenology of connectivity (see for example
<xref ref-type="bibr" rid="ref-55">55</xref>–
<xref ref-type="bibr" rid="ref-59">59</xref>), there are far less data on how this information can be used for therapeutic purposes. However, an understanding of distributed networks could identify regions of the brain that are critical for seizure generation or for any relevant cognitive function, even if that area of the brain is not the obviously abnormal piece of tissue. An excellent example of this is from a study of patients with periventricular nodular heterotopia associated with seizures
<sup><xref ref-type="bibr" rid="ref-60">60</xref></sup>. Functional MRI was used to identify aberrant functional connectivity between the heterotopia and normal-looking cortex. Abnormal connectivity was identified between the heterotopia and areas of the cortex that were not consistent across patients. Transcranial magnetic stimulation (TMS) was used to show that the connected cortical areas were hyperexcitable, suggesting that the authors had identified an epileptogenic network. This raises the possibility that TMS targeted at the cortical site identified using network approaches could reduce seizures in patients with deep-seated epileptogenic foci.</p>
<p>Another potential use of network approaches is in epilepsy surgery. Despite state-of-the-art selection methods, investigations for identifying the epileptogenic focus, and excellent surgical technique, many patients with epilepsy fail to become seizure free. In these patients, it is possible that the epileptogenic networks have not been adequately disrupted by surgery and therefore a more detailed understanding of the network could lead to tailored resections based on that information. A variety of network measures have been used to describe the distributed abnormal networks in patients with focal epilepsy, particularly those with MTS
<sup><xref ref-type="bibr" rid="ref-55">55</xref>,
<xref ref-type="bibr" rid="ref-61">61</xref>–
<xref ref-type="bibr" rid="ref-63">63</xref></sup>. Patients who subsequently failed to become seizure free often had different network changes to those patients who did become seizure free. The next challenge is to establish how that information can be used to maximize surgical outcomes.</p>
</sec>
<sec sec-type="conclusions">
<title>Conclusion</title>
<p>The goal of this article was not to provide an exhaustive review of network science as applied to epilepsy but rather to provide examples of how these methods have enormous potential to contribute to the treatment of patients with epilepsy. The overriding concept is that an understanding of networks from genetic, local neural, and global brain data can identify new therapeutic targets for both seizures and associated comorbidities. Modification of these targets can be with drugs, stimulation devices, surgical approaches, and TMS, ultimately maximizing the quality of life of patients with epilepsy.</p>
</sec>
</body>
<back>
<ref-list>
<ref id="ref-1">
<label>1</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Raspall-Chaure</surname><given-names>M</given-names></name><name><surname>Neville</surname><given-names>BG</given-names></name><name><surname>Scott</surname><given-names>RC</given-names></name></person-group>:
<article-title>The medical management of the epilepsies in children: conceptual and practical considerations.</article-title>
<source/><italic>Lancet Neurol.</italic>
<year>2008</year>;<volume>7</volume>(<issue>1</issue>):<fpage>57</fpage>–<lpage>69</lpage>.
<pub-id pub-id-type="doi">10.1016/S1474-4422(07)70324-1</pub-id>
<pub-id pub-id-type="pmid">18093563</pub-id></mixed-citation>
</ref>
<ref id="ref-2">
<label>2</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Reilly</surname><given-names>C</given-names></name><name><surname>Atkinson</surname><given-names>P</given-names></name><name><surname>Das</surname><given-names>KB</given-names></name><etal></etal></person-group>:
<article-title>Factors associated with quality of life in active childhood epilepsy: a population-based study.</article-title>
<source/><italic>Eur J Paediatr Neurol.</italic>
<year>2015</year>;<volume>19</volume>(<issue>3</issue>):<fpage>308</fpage>–<lpage>13</lpage>.
<pub-id pub-id-type="doi">10.1016/j.ejpn.2014.12.022</pub-id>
<pub-id pub-id-type="pmid">25596900</pub-id></mixed-citation>
</ref>
<ref id="ref-3">
<label>3</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kwan</surname><given-names>P</given-names></name><name><surname>Brodie</surname><given-names>MJ</given-names></name></person-group>:
<article-title>Early identification of refractory epilepsy.</article-title>
<source/><italic>N Engl J Med.</italic>
<year>2000</year>;<volume>342</volume>(<issue>5</issue>):<fpage>314</fpage>–<lpage>9</lpage>.
<pub-id pub-id-type="doi">10.1056/NEJM200002033420503</pub-id>
<pub-id pub-id-type="pmid">10660394</pub-id></mixed-citation>
</ref>
<ref id="ref-4">
<label>4</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Koneski</surname><given-names>JA</given-names></name><name><surname>Casella</surname><given-names>EB</given-names></name><name><surname>Agertt</surname><given-names>F</given-names></name><etal></etal></person-group>:
<article-title>Efficacy and safety of methylphenidate in treating ADHD symptoms in children and adolescents with uncontrolled seizures: a Brazilian sample study and literature review.</article-title>
<source/><italic>Epilepsy Behav.</italic>
<year>2011</year>;<volume>21</volume>(<issue>3</issue>):<fpage>228</fpage>–<lpage>32</lpage>.
<pub-id pub-id-type="doi">10.1016/j.yebeh.2011.02.029</pub-id>
<pub-id pub-id-type="pmid">21524941</pub-id></mixed-citation>
</ref>
<ref id="ref-5">
<label>5</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shalev</surname><given-names>R</given-names></name></person-group>:
<article-title>Good news: methylphenidate for ADHD in epilepsy.</article-title>
<source/><italic>Dev Med Child Neurol.</italic>
<year>2013</year>;<volume>55</volume>(<issue>7</issue>):<fpage>590</fpage>–<lpage>1</lpage>.
<pub-id pub-id-type="doi">10.1111/dmcn.12111</pub-id>
<pub-id pub-id-type="pmid">23480458</pub-id></mixed-citation>
</ref>
<ref id="ref-6">
<label>6</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Karouni</surname><given-names>M</given-names></name><name><surname>Arulthas</surname><given-names>S</given-names></name><name><surname>Larsson</surname><given-names>PG</given-names></name><etal></etal></person-group>:
<article-title>Psychiatric comorbidity in patients with epilepsy: a population-based study.</article-title>
<source/><italic>Eur J Clin Pharmacol.</italic>
<year>2010</year>;<volume>66</volume>(<issue>11</issue>):<fpage>1151</fpage>–<lpage>60</lpage>.
<pub-id pub-id-type="doi">10.1007/s00228-010-0861-y</pub-id>
<pub-id pub-id-type="pmid">20669014</pub-id></mixed-citation>
</ref>
<ref id="ref-7">
<label>7</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kanner</surname><given-names>AM</given-names></name></person-group>:
<article-title>The use of psychotropic drugs in epilepsy: what every neurologist should know.</article-title>
<source/><italic>Semin Neurol.</italic>
<year>2008</year>;<volume>28</volume>(<issue>3</issue>):<fpage>379</fpage>–<lpage>88</lpage>.
<pub-id pub-id-type="doi">10.1055/s-2008-1079342</pub-id>
<pub-id pub-id-type="pmid">18777484</pub-id></mixed-citation>
</ref>
<ref id="ref-8">
<label>8</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Stam</surname><given-names>CJ</given-names></name></person-group>:
<article-title>Modern network science of neurological disorders.</article-title>
<source/><italic>Nat Rev Neurosci.</italic>
<year>2014</year>;<volume>15</volume>(<issue>10</issue>):<fpage>683</fpage>–<lpage>95</lpage>.
<pub-id pub-id-type="doi">10.1038/nrn3801</pub-id>
<pub-id pub-id-type="pmid">25186238</pub-id></mixed-citation>
</ref>
<ref id="ref-9">
<label>9</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Berg</surname><given-names>AT</given-names></name><name><surname>Berkovic</surname><given-names>SF</given-names></name><name><surname>Brodie</surname><given-names>MJ</given-names></name><etal></etal></person-group>:
<article-title>Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005–2009.</article-title>
<source/><italic>Epilepsia.</italic>
<year>2010</year>;<volume>51</volume>(<issue>4</issue>):<fpage>676</fpage>–<lpage>85</lpage>.
<pub-id pub-id-type="doi">10.1111/j.1528-1167.2010.02522.x</pub-id>
<pub-id pub-id-type="pmid">20196795</pub-id></mixed-citation>
</ref>
<ref id="ref-10">
<label>10</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hannan</surname><given-names>S</given-names></name><name><surname>Cross</surname><given-names>JH</given-names></name><name><surname>Scott</surname><given-names>RC</given-names></name><etal></etal></person-group>:
<article-title>The effects of epilepsy surgery on emotions, behavior, and psychosocial impairment in children and adolescents with drug-resistant epilepsy: a prospective study.</article-title>
<source/><italic>Epilepsy Behav.</italic>
<year>2009</year>;<volume>15</volume>(<issue>3</issue>):<fpage>318</fpage>–<lpage>24</lpage>.
<pub-id pub-id-type="doi">10.1016/j.yebeh.2009.04.007</pub-id>
<pub-id pub-id-type="pmid">19362603</pub-id></mixed-citation>
</ref>
<ref id="ref-11">
<label>11</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Skirrow</surname><given-names>C</given-names></name><name><surname>Cross</surname><given-names>JH</given-names></name><name><surname>Cormack</surname><given-names>F</given-names></name><etal></etal></person-group>:
<article-title>Long-term intellectual outcome after temporal lobe surgery in childhood.</article-title>
<source/><italic>Neurology.</italic>
<year>2011</year>;<volume>76</volume>(<issue>15</issue>):<fpage>1330</fpage>–<lpage>7</lpage>.
<pub-id pub-id-type="doi">10.1212/WNL.0b013e31821527f0</pub-id>
<!--<pub-id pub-id-type="pmcid">3090063</pub-id>-->
<pub-id pub-id-type="pmid">21482948</pub-id></mixed-citation>
</ref>
<ref id="ref-12">
<label>12</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lucas</surname><given-names>MM</given-names></name><name><surname>Lenck-Santini</surname><given-names>PP</given-names></name><name><surname>Holmes</surname><given-names>GL</given-names></name><etal></etal></person-group>:
<article-title>Impaired cognition in rats with cortical dysplasia: additional impact of early-life seizures.</article-title>
<source/><italic>Brain.</italic>
<year>2011</year>;<volume>134</volume>(<issue>Pt 6</issue>):<fpage>1684</fpage>–<lpage>93</lpage>.
<pub-id pub-id-type="doi">10.1093/brain/awr087</pub-id>
<!--<pub-id pub-id-type="pmcid">3102240</pub-id>-->
<pub-id pub-id-type="pmid">21602270</pub-id></mixed-citation>
</ref>
<ref id="ref-13">
<label>13</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Howell</surname><given-names>KB</given-names></name><name><surname>Harvey</surname><given-names>AS</given-names></name><name><surname>Archer</surname><given-names>JS</given-names></name></person-group>:
<article-title>Epileptic encephalopathy: Use and misuse of a clinically and conceptually important concept.</article-title>
<source/><italic>Epilepsia.</italic>
<year>2016</year>;<volume>57</volume>(<issue>3</issue>):<fpage>343</fpage>–<lpage>7</lpage>.
<pub-id pub-id-type="doi">10.1111/epi.13306</pub-id>
<pub-id pub-id-type="pmid">26778176</pub-id></mixed-citation>
</ref>
<ref id="ref-14">
<label>14</label>
<mixed-citation publication-type="journal">
<collab>Epi4K Consortium</collab>:
<article-title>Epi4K: gene discovery in 4,000 genomes.</article-title>
<source/><italic>Epilepsia.</italic>
<year>2012</year>;<volume>53</volume>(<issue>8</issue>):<fpage>1457</fpage>–<lpage>67</lpage>.
<pub-id pub-id-type="doi">10.1111/j.1528-1167.2012.03511.x</pub-id>
<!--<pub-id pub-id-type="pmcid">3418423</pub-id>-->
<pub-id pub-id-type="pmid">22642626</pub-id></mixed-citation>
</ref>
<ref id="ref-15">
<label>15</label>
<mixed-citation publication-type="journal">
<collab>EuroEPINOMICS-RES Consortium; Epilepsy Phenome/Genome Project; Epi4K Consortium</collab>:
<article-title>
<italic>De novo</italic> mutations in synaptic transmission genes including
<italic>DNM1</italic> cause epileptic encephalopathies.</article-title>
<source/><italic>Am J Hum Genet.</italic>
<year>2014</year>;<volume>95</volume>(<issue>4</issue>):<fpage>360</fpage>–<lpage>70</lpage>.
<pub-id pub-id-type="doi">10.1016/j.ajhg.2014.08.013</pub-id>
<!--<pub-id pub-id-type="pmcid">4185114</pub-id>-->
<pub-id pub-id-type="pmid">25262651</pub-id></mixed-citation>
</ref>
<ref id="ref-16">
<label>16</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kearney</surname><given-names>JA</given-names></name></person-group>:
<article-title>Epi4K Phase I: Gene Discovery in Epileptic Encephalopathies by Exome Sequencing.</article-title>
<source/><italic>Epilepsy Curr.</italic>
<year>2014</year>;<volume>14</volume>(<issue>4</issue>):<fpage>208</fpage>–<lpage>10</lpage>.
<pub-id pub-id-type="doi">10.5698/1535-7597-14.4.208</pub-id>
<!--<pub-id pub-id-type="pmcid">4120393</pub-id>-->
<pub-id pub-id-type="pmid">25170321</pub-id></mixed-citation>
</ref>
<ref id="ref-17">
<label>17</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Oliver</surname><given-names>KL</given-names></name><name><surname>Lukic</surname><given-names>V</given-names></name><name><surname>Thorne</surname><given-names>NP</given-names></name><etal></etal></person-group>:
<article-title>Harnessing gene expression networks to prioritize candidate epileptic encephalopathy genes.</article-title>
<source/><italic>PLoS One.</italic>
<year>2014</year>;<volume>9</volume>(<issue>7</issue>):<fpage>e102079</fpage>.
<pub-id pub-id-type="doi">10.1371/journal.pone.0102079</pub-id>
<!--<pub-id pub-id-type="pmcid">4090166</pub-id>-->
<pub-id pub-id-type="pmid">25014031</pub-id></mixed-citation>
</ref>
<ref id="ref-18">
<label>18</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lang</surname><given-names>M</given-names></name><name><surname>Wither</surname><given-names>RG</given-names></name><name><surname>Colic</surname><given-names>S</given-names></name><etal></etal></person-group>:
<article-title>Rescue of behavioral and EEG deficits in male and female Mecp2-deficient mice by delayed
<italic>Mecp2</italic> gene reactivation.</article-title>
<source/><italic>Hum Mol Genet.</italic>
<year>2014</year>;<volume>23</volume>(<issue>2</issue>):<fpage>303</fpage>–<lpage>18</lpage>.
<pub-id pub-id-type="doi">10.1093/hmg/ddt421</pub-id>
<!--<pub-id pub-id-type="pmcid">3869352</pub-id>-->
<pub-id pub-id-type="pmid">24009314</pub-id></mixed-citation>
</ref>
<ref id="ref-19">
<label>19</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><collab>Epi4K Consortium; Epilepsy Phenome/Genome Project,</collab><name><surname> Allen</surname><given-names>AS</given-names></name><etal></etal></person-group>:
<article-title>
<italic>De novo</italic> mutations in epileptic encephalopathies.</article-title>
<source/><italic>Nature.</italic>
<year>2013</year>;<volume>501</volume>(<issue>7466</issue>):<fpage>217</fpage>–<lpage>21</lpage>.
<pub-id pub-id-type="doi">10.1038/nature12439</pub-id>
<!--<pub-id pub-id-type="pmcid">3773011</pub-id>-->
<pub-id pub-id-type="pmid">23934111</pub-id></mixed-citation>
</ref>
<ref id="ref-20">
<label>20</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Heinig</surname><given-names>M</given-names></name><name><surname>Petretto</surname><given-names>E</given-names></name><name><surname>Wallace</surname><given-names>C</given-names></name><etal></etal></person-group>:
<article-title>A
<italic>trans</italic>-acting locus regulates an anti-viral expression network and type 1 diabetes risk.</article-title>
<source/><italic>Nature.</italic>
<year>2010</year>;<volume>467</volume>(<issue>7314</issue>):<fpage>460</fpage>–<lpage>4</lpage>.
<pub-id pub-id-type="doi">10.1038/nature09386</pub-id>
<!--<pub-id pub-id-type="pmcid">3657719</pub-id>-->
<pub-id pub-id-type="pmid">20827270</pub-id></mixed-citation>
</ref>
<ref id="ref-21">
<label>21</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Voineagu</surname><given-names>I</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Johnston</surname><given-names>P</given-names></name><etal></etal></person-group>:
<article-title>Transcriptomic analysis of autistic brain reveals convergent molecular pathology.</article-title>
<source/><italic>Nature.</italic>
<year>2011</year>;<volume>474</volume>(<issue>7351</issue>):<fpage>380</fpage>–<lpage>4</lpage>.
<pub-id pub-id-type="doi">10.1038/nature10110</pub-id>
<!--<pub-id pub-id-type="pmcid">3607626</pub-id>-->
<pub-id pub-id-type="pmid">21614001</pub-id></mixed-citation>
</ref>
<ref id="ref-22">
<label>22</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Parikshak</surname><given-names>NN</given-names></name><name><surname>Luo</surname><given-names>R</given-names></name><name><surname>Zhang</surname><given-names>A</given-names></name><etal></etal></person-group>:
<article-title>Integrative functional genomic analyses implicate specific molecular pathways and circuits in autism.</article-title>
<source/><italic>Cell.</italic>
<year>2013</year>;<volume>155</volume>(<issue>5</issue>):<fpage>1008</fpage>–<lpage>21</lpage>.
<pub-id pub-id-type="doi">10.1016/j.cell.2013.10.031</pub-id>
<!--<pub-id pub-id-type="pmcid">3934107</pub-id>-->
<pub-id pub-id-type="pmid">24267887</pub-id></mixed-citation>
</ref>
<ref id="ref-23">
<label>23</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wang</surname><given-names>Z</given-names></name><name><surname>Fan</surname><given-names>Y</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><etal></etal></person-group>:
<article-title>Transcriptome analysis of the hippocampus in novel rat model of febrile seizures.</article-title>
<source/><italic>PLoS One.</italic>
<year>2014</year>;<volume>9</volume>(<issue>4</issue>):<fpage>e95237</fpage>.
<pub-id pub-id-type="doi">10.1371/journal.pone.0095237</pub-id>
<!--<pub-id pub-id-type="pmcid">3988142</pub-id>-->
<pub-id pub-id-type="pmid">24736375</pub-id></mixed-citation>
</ref>
<ref id="ref-24">
<label>24</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Moreira-Filho</surname><given-names>CA</given-names></name><name><surname>Bando</surname><given-names>SY</given-names></name><name><surname>Bertonha</surname><given-names>FB</given-names></name><etal></etal></person-group>:
<article-title>Community structure analysis of transcriptional networks reveals distinct molecular pathways for early- and late-onset temporal lobe epilepsy with childhood febrile seizures.</article-title>
<source/><italic>PLoS One.</italic>
<year>2015</year>;<volume>10</volume>(<issue>5</issue>):<fpage>e0128174</fpage>.
<pub-id pub-id-type="doi">10.1371/journal.pone.0128174</pub-id>
<!--<pub-id pub-id-type="pmcid">4444281</pub-id>-->
<pub-id pub-id-type="pmid">26011637</pub-id></mixed-citation>
</ref>
<ref id="ref-25">
<label>25</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bando</surname><given-names>SY</given-names></name><name><surname>Silva</surname><given-names>FN</given-names></name><name><surname>Costa</surname><given-names>Lda F</given-names></name><etal></etal></person-group>:
<article-title>Complex network analysis of CA3 transcriptome reveals pathogenic and compensatory pathways in refractory temporal lobe epilepsy.</article-title>
<source/><italic>PLoS One.</italic>
<year>2013</year>;<volume>8</volume>(<issue>11</issue>):<fpage>e79913</fpage>.
<pub-id pub-id-type="doi">10.1371/journal.pone.0079913</pub-id>
<!--<pub-id pub-id-type="pmcid">3836787</pub-id>-->
<pub-id pub-id-type="pmid">24278214</pub-id></mixed-citation>
</ref>
<ref id="ref-26">
<label>26</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Johnson</surname><given-names>MR</given-names></name><name><surname>Behmoaras</surname><given-names>J</given-names></name><name><surname>Bottolo</surname><given-names>L</given-names></name><etal></etal></person-group>:
<article-title>Systems genetics identifies Sestrin 3 as a regulator of a proconvulsant gene network in human epileptic hippocampus.</article-title>
<source/><italic>Nat Commun.</italic>
<year>2015</year>;<volume>6</volume>: 6031.
<pub-id pub-id-type="doi">10.1038/ncomms7031</pub-id>
<!--<pub-id pub-id-type="pmcid">4627576</pub-id>-->
<pub-id pub-id-type="pmid">25615886</pub-id></mixed-citation>
</ref>
<ref id="ref-27">
<label>27</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lam</surname><given-names>JK</given-names></name><name><surname>Chow</surname><given-names>MY</given-names></name><name><surname>Zhang</surname><given-names>Y</given-names></name><etal></etal></person-group>:
<article-title>siRNA Versus miRNA as Therapeutics for Gene Silencing.</article-title>
<source/><italic>Mol Ther Nucleic Acids.</italic>
<year>2015</year>;<volume>4</volume>:<fpage>e252</fpage>.
<pub-id pub-id-type="doi">10.1038/mtna.2015.23</pub-id>
<pub-id pub-id-type="pmid">26372022</pub-id></mixed-citation>
</ref>
<ref id="ref-28">
<label>28</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>O'Keefe</surname><given-names>J</given-names></name><name><surname>Nadel</surname><given-names>L</given-names></name></person-group>:
<article-title>The hippocampus as a cognitive map</article-title>. Oxford: Clarendon Press;<year>1978</year>
<ext-link ext-link-type="uri" xlink:href="http://www.cognitivemap.net/HCMpdf/HCMComplete.pdf">Reference Source</ext-link>
</mixed-citation>
</ref>
<ref id="ref-29">
<label>29</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Muller</surname><given-names>R</given-names></name></person-group>:
<article-title>A quarter of a century of place cells.</article-title>
<source/><italic>Neuron.</italic>
<year>1996</year>;<volume>17</volume>(<issue>5</issue>):<fpage>813</fpage>–<lpage>22</lpage>.
<pub-id pub-id-type="doi">10.1016/S0896-6273(00)80214-7</pub-id>
<pub-id pub-id-type="pmid">8938115</pub-id></mixed-citation>
</ref>
<ref id="ref-30">
<label>30</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Quian Quiroga</surname><given-names>R</given-names></name><name><surname>Kraskov</surname><given-names>A</given-names></name><name><surname>Mormann</surname><given-names>F</given-names></name><etal></etal></person-group>:
<article-title>Single-cell responses to face adaptation in the human medial temporal lobe.</article-title>
<source/><italic>Neuron.</italic>
<year>2014</year>;<volume>84</volume>(<issue>2</issue>):<fpage>363</fpage>–<lpage>9</lpage>.
<pub-id pub-id-type="doi">10.1016/j.neuron.2014.09.006</pub-id>
<!--<pub-id pub-id-type="pmcid">4210637</pub-id>-->
<pub-id pub-id-type="pmid">25263754</pub-id></mixed-citation>
</ref>
<ref id="ref-31">
<label>31</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Viskontas</surname><given-names>IV</given-names></name><name><surname>Quiroga</surname><given-names>RQ</given-names></name><name><surname>Fried</surname><given-names>I</given-names></name></person-group>:
<article-title>Human medial temporal lobe neurons respond preferentially to personally relevant images.</article-title>
<source/><italic>Proc Natl Acad Sci U S A.</italic>
<year>2009</year>;<volume>106</volume>(<issue>50</issue>):<fpage>21329</fpage>–<lpage>34</lpage>.
<pub-id pub-id-type="doi">10.1073/pnas.0902319106</pub-id>
<!--<pub-id pub-id-type="pmcid">2795562</pub-id>-->
<pub-id pub-id-type="pmid">19955441</pub-id></mixed-citation>
</ref>
<ref id="ref-32">
<label>32</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Fried</surname><given-names>I</given-names></name><name><surname>MacDonald</surname><given-names>KA</given-names></name><name><surname>Wilson</surname><given-names>CL</given-names></name></person-group>:
<article-title>Single neuron activity in human hippocampus and amygdala during recognition of faces and objects.</article-title>
<source/><italic>Neuron.</italic>
<year>1997</year>;<volume>18</volume>(<issue>5</issue>):<fpage>753</fpage>–<lpage>65</lpage>.
<pub-id pub-id-type="doi">10.1016/S0896-6273(00)80315-3</pub-id>
<pub-id pub-id-type="pmid">9182800</pub-id></mixed-citation>
</ref>
<ref id="ref-33">
<label>33</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Gray</surname><given-names>CM</given-names></name><name><surname>König</surname><given-names>P</given-names></name><name><surname>Engel</surname><given-names>AK</given-names></name><etal></etal></person-group>:
<article-title>Oscillatory responses in cat visual cortex exhibit inter-columnar synchronization which reflects global stimulus properties.</article-title>
<source/><italic>Nature.</italic>
<year>1989</year>;<volume>338</volume>(<issue>6213</issue>):<fpage>334</fpage>–<lpage>7</lpage>.
<pub-id pub-id-type="doi">10.1038/338334a0</pub-id>
<pub-id pub-id-type="pmid">2922061</pub-id></mixed-citation>
</ref>
<ref id="ref-34">
<label>34</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Kilavik</surname><given-names>BE</given-names></name><name><surname>Confais</surname><given-names>J</given-names></name><name><surname>Riehle</surname><given-names>A</given-names></name></person-group>:
<article-title>Signs of timing in motor cortex during movement preparation and cue anticipation.</article-title>
<source/><italic>Adv Exp Med Biol.</italic>
<year>2014</year>;<volume>829</volume>:<fpage>121</fpage>–<lpage>42</lpage>.
<pub-id pub-id-type="doi">10.1007/978-1-4939-1782-2_7</pub-id>
<pub-id pub-id-type="pmid">25358708</pub-id></mixed-citation>
</ref>
<ref id="ref-35">
<label>35</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Georgopoulos</surname><given-names>AP</given-names></name><name><surname>Kalaska</surname><given-names>JF</given-names></name><name><surname>Caminiti</surname><given-names>R</given-names></name><etal></etal></person-group>:
<article-title>On the relations between the direction of two-dimensional arm movements and cell discharge in primate motor cortex.</article-title>
<source/><italic>J Neurosci.</italic>
<year>1982</year>;<volume>2</volume>(<issue>11</issue>):<fpage>1527</fpage>–<lpage>37</lpage>.
<pub-id pub-id-type="pmid">7143039</pub-id></mixed-citation>
</ref>
<ref id="ref-36">
<label>36</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Tyler</surname><given-names>AL</given-names></name><name><surname>Mahoney</surname><given-names>JM</given-names></name><name><surname>Richard</surname><given-names>GR</given-names></name><etal></etal></person-group>:
<article-title>Functional network changes in hippocampal CA1 after status epilepticus predict spatial memory deficits in rats.</article-title>
<source/><italic>J Neurosci.</italic>
<year>2012</year>;<volume>32</volume>(<issue>33</issue>):<fpage>11365</fpage>–<lpage>76</lpage>.
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.1516-12.2012</pub-id>
<!--<pub-id pub-id-type="pmcid">3536550</pub-id>-->
<pub-id pub-id-type="pmid">22895719</pub-id></mixed-citation>
</ref>
<ref id="ref-37">
<label>37</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Wilson</surname><given-names>MA</given-names></name><name><surname>McNaughton</surname><given-names>BL</given-names></name></person-group>:
<article-title>Dynamics of the hippocampal ensemble code for space.</article-title>
<source/><italic>Science.</italic>
<year>1993</year>;<volume>261</volume>(<issue>5124</issue>):<fpage>1055</fpage>–<lpage>8</lpage>.
<pub-id pub-id-type="doi">10.1126/science.8351520</pub-id>
<pub-id pub-id-type="pmid">8351520</pub-id></mixed-citation>
</ref>
<ref id="ref-38">
<label>38</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Levi</surname><given-names>R</given-names></name><name><surname>Camhi</surname><given-names>JM</given-names></name></person-group>:
<article-title>Population vector coding by the giant interneurons of the cockroach.</article-title>
<source/><italic>J Neurosci.</italic>
<year>2000</year>;<volume>20</volume>(<issue>10</issue>):<fpage>3822</fpage>–<lpage>9</lpage>.
<pub-id pub-id-type="pmid">10804222</pub-id></mixed-citation>
</ref>
<ref id="ref-39">
<label>39</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lenck-Santini</surname><given-names>PP</given-names></name><name><surname>Holmes</surname><given-names>GL</given-names></name></person-group>:
<article-title>Altered phase precession and compression of temporal sequences by place cells in epileptic rats.</article-title>
<source/><italic>J Neurosci.</italic>
<year>2008</year>;<volume>28</volume>(<issue>19</issue>):<fpage>5053</fpage>–<lpage>62</lpage>.
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.5024-07.2008</pub-id>
<!--<pub-id pub-id-type="pmcid">3304586</pub-id>-->
<pub-id pub-id-type="pmid">18463258</pub-id></mixed-citation>
</ref>
<ref id="ref-40">
<label>40</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shatskikh</surname><given-names>T</given-names></name><name><surname>Zhao</surname><given-names>Q</given-names></name><name><surname>Zhou</surname><given-names>JL</given-names></name><etal></etal></person-group>:
<article-title>Effect of topiramate on cognitive function and single units from hippocampal place cells following status epilepticus.</article-title>
<source/><italic>Epilepsy Behav.</italic>
<year>2009</year>;<volume>14</volume>(<issue>1</issue>):<fpage>40</fpage>–<lpage>7</lpage>.
<pub-id pub-id-type="doi">10.1016/j.yebeh.2008.09.030</pub-id>
<pub-id pub-id-type="pmid">18929683</pub-id></mixed-citation>
</ref>
<ref id="ref-41">
<label>41</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Karnam</surname><given-names>HB</given-names></name><name><surname>Zhou</surname><given-names>JL</given-names></name><name><surname>Huang</surname><given-names>LT</given-names></name><etal></etal></person-group>:
<article-title>Early life seizures cause long-standing impairment of the hippocampal map.</article-title>
<source/><italic>Exp Neurol.</italic>
<year>2009</year>;<volume>217</volume>(<issue>2</issue>):<fpage>378</fpage>–<lpage>87</lpage>.
<pub-id pub-id-type="doi">10.1016/j.expneurol.2009.03.028</pub-id>
<!--<pub-id pub-id-type="pmcid">2791529</pub-id>-->
<pub-id pub-id-type="pmid">19345685</pub-id></mixed-citation>
</ref>
<ref id="ref-42">
<label>42</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lin</surname><given-names>H</given-names></name><name><surname>Hangya</surname><given-names>B</given-names></name><name><surname>Fox</surname><given-names>SE</given-names></name><etal></etal></person-group>:
<article-title>Repetitive convulsant-induced seizures reduce the number but not precision of hippocampal place cells.</article-title>
<source/><italic>J Neurosci.</italic>
<year>2012</year>;<volume>32</volume>(<issue>12</issue>):<fpage>4163</fpage>–<lpage>78</lpage>.
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.4900-11.2012</pub-id>
<!--<pub-id pub-id-type="pmcid">3743017</pub-id>-->
<pub-id pub-id-type="pmid">22442080</pub-id></mixed-citation>
</ref>
<ref id="ref-43">
<label>43</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Holmes</surname><given-names>GL</given-names></name><name><surname>Thompson</surname><given-names>JL</given-names></name><name><surname>Marchi</surname><given-names>T</given-names></name><etal></etal></person-group>:
<article-title>Behavioral effects of kainic acid administration on the immature brain.</article-title>
<source/><italic>Epilepsia.</italic>
<year>1988</year>;<volume>29</volume>(<issue>6</issue>):<fpage>721</fpage>–<lpage>30</lpage>.
<pub-id pub-id-type="doi">10.1111/j.1528-1157.1988.tb04226.x</pub-id>
<pub-id pub-id-type="pmid">3191887</pub-id></mixed-citation>
</ref>
<ref id="ref-44">
<label>44</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hort</surname><given-names>J</given-names></name><name><surname>Broźek</surname><given-names>G</given-names></name><name><surname>Mares</surname><given-names>P</given-names></name><etal></etal></person-group>:
<article-title>Cognitive functions after pilocarpine-induced status epilepticus: changes during silent period precede appearance of spontaneous recurrent seizures.</article-title>
<source/><italic>Epilepsia.</italic>
<year>1999</year>;<volume>40</volume>(<issue>9</issue>):<fpage>1177</fpage>–<lpage>83</lpage>.
<pub-id pub-id-type="doi">10.1111/j.1528-1157.1999.tb00845.x</pub-id>
<pub-id pub-id-type="pmid">10487179</pub-id></mixed-citation>
</ref>
<ref id="ref-45">
<label>45</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Muller</surname><given-names>RU</given-names></name><name><surname>Huang</surname><given-names>LT</given-names></name><etal></etal></person-group>:
<article-title>Seizure-induced changes in place cell physiology: relationship to spatial memory.</article-title>
<source/><italic>J Neurosci.</italic>
<year>2003</year>;<volume>23</volume>(<issue>37</issue>):<fpage>11505</fpage>–<lpage>15</lpage>.
<pub-id pub-id-type="pmid">14684854</pub-id></mixed-citation>
</ref>
<ref id="ref-46">
<label>46</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Jenks</surname><given-names>KR</given-names></name><name><surname>Lucas</surname><given-names>MM</given-names></name><name><surname>Duffy</surname><given-names>BA</given-names></name><etal></etal></person-group>:
<article-title>Enrichment and training improve cognition in rats with cortical malformations.</article-title>
<source/><italic>PLoS One.</italic>
<year>2013</year>;<volume>8</volume>(<issue>12</issue>):<fpage>e84492</fpage>.
<pub-id pub-id-type="doi">10.1371/journal.pone.0084492</pub-id>
<!--<pub-id pub-id-type="pmcid">3866176</pub-id>-->
<pub-id pub-id-type="pmid">24358362</pub-id></mixed-citation>
</ref>
<ref id="ref-47">
<label>47</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Suthana</surname><given-names>N</given-names></name><name><surname>Haneef</surname><given-names>Z</given-names></name><name><surname>Stern</surname><given-names>J</given-names></name><etal></etal></person-group>:
<article-title>Memory enhancement and deep-brain stimulation of the entorhinal area.</article-title>
<source/><italic>N Engl J Med.</italic>
<year>2012</year>;<volume>366</volume>(<issue>6</issue>):<fpage>502</fpage>–<lpage>10</lpage>.
<pub-id pub-id-type="doi">10.1056/NEJMoa1107212</pub-id>
<!--<pub-id pub-id-type="pmcid">3447081</pub-id>-->
<pub-id pub-id-type="pmid">22316444</pub-id></mixed-citation>
</ref>
<ref id="ref-48">
<label>48</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Roux</surname><given-names>L</given-names></name><name><surname>Buzsáki</surname><given-names>G</given-names></name></person-group>:
<article-title>Tasks for inhibitory interneurons in intact brain circuits.</article-title>
<source/><italic>Neuropharmacology.</italic>
<year>2015</year>;<volume>88</volume>:<fpage>10</fpage>–<lpage>23</lpage>.
<pub-id pub-id-type="doi">10.1016/j.neuropharm.2014.09.011</pub-id>
<!--<pub-id pub-id-type="pmcid">4254329</pub-id>-->
<pub-id pub-id-type="pmid">25239808</pub-id></mixed-citation>
</ref>
<ref id="ref-49">
<label>49</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hunt</surname><given-names>RF</given-names></name><name><surname>Girskis</surname><given-names>KM</given-names></name><name><surname>Rubenstein</surname><given-names>JL</given-names></name><etal></etal></person-group>:
<article-title>GABA progenitors grafted into the adult epileptic brain control seizures and abnormal behavior.</article-title>
<source/><italic>Nat Neurosci.</italic>
<year>2013</year>;<volume>16</volume>(<issue>6</issue>):<fpage>692</fpage>–<lpage>7</lpage>.
<pub-id pub-id-type="doi">10.1038/nn.3392</pub-id>
<!--<pub-id pub-id-type="pmcid">3665733</pub-id>-->
<pub-id pub-id-type="pmid">23644485</pub-id></mixed-citation>
</ref>
<ref id="ref-50">
<label>50</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Waldau</surname><given-names>B</given-names></name><name><surname>Hattiangady</surname><given-names>B</given-names></name><name><surname>Kuruba</surname><given-names>R</given-names></name><etal></etal></person-group>:
<article-title>Medial ganglionic eminence-derived neural stem cell grafts ease spontaneous seizures and restore GDNF expression in a rat model of chronic temporal lobe epilepsy.</article-title>
<source/><italic>Stem Cells.</italic>
<year>2010</year>;<volume>28</volume>(<issue>7</issue>):<fpage>1153</fpage>–<lpage>64</lpage>.
<pub-id pub-id-type="doi">10.1002/stem.446</pub-id>
<!--<pub-id pub-id-type="pmcid">2933789</pub-id>-->
<pub-id pub-id-type="pmid">20506409</pub-id></mixed-citation>
</ref>
<ref id="ref-51">
<label>51</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Henderson</surname><given-names>KW</given-names></name><name><surname>Gupta</surname><given-names>J</given-names></name><name><surname>Tagliatela</surname><given-names>S</given-names></name><etal></etal></person-group>:
<article-title>Long-term seizure suppression and optogenetic analyses of synaptic connectivity in epileptic mice with hippocampal grafts of GABAergic interneurons.</article-title>
<source/><italic>J Neurosci.</italic>
<year>2014</year>;<volume>34</volume>(<issue>40</issue>):<fpage>13492</fpage>–<lpage>504</lpage>.
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.0005-14.2014</pub-id>
<!--<pub-id pub-id-type="pmcid">4180479</pub-id>-->
<pub-id pub-id-type="pmid">25274826</pub-id></mixed-citation>
</ref>
<ref id="ref-52">
<label>52</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Krook-Magnuson</surname><given-names>E</given-names></name><name><surname>Armstrong</surname><given-names>C</given-names></name><name><surname>Oijala</surname><given-names>M</given-names></name><etal></etal></person-group>:
<article-title>On-demand optogenetic control of spontaneous seizures in temporal lobe epilepsy.</article-title>
<source/><italic>Nat Commun.</italic>
<year>2013</year>;<volume>4</volume>: 1376.
<pub-id pub-id-type="doi">10.1038/ncomms2376</pub-id>
<!--<pub-id pub-id-type="pmcid">3562457</pub-id>-->
<pub-id pub-id-type="pmid">23340416</pub-id></mixed-citation>
</ref>
<ref id="ref-53">
<label>53</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Hernan</surname><given-names>AE</given-names></name><name><surname>Alexander</surname><given-names>A</given-names></name><name><surname>Lenck-Santini</surname><given-names>PP</given-names></name><etal></etal></person-group>:
<article-title>Attention deficit associated with early life interictal spikes in a rat model is improved with ACTH.</article-title>
<source/><italic>PLoS One.</italic>
<year>2014</year>;<volume>9</volume>(<issue>2</issue>):<fpage>e89812</fpage>.
<pub-id pub-id-type="doi">10.1371/journal.pone.0089812</pub-id>
<!--<pub-id pub-id-type="pmcid">3933669</pub-id>-->
<pub-id pub-id-type="pmid">24587054</pub-id></mixed-citation>
</ref>
<ref id="ref-54">
<label>54</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Darke</surname><given-names>K</given-names></name><name><surname>Edwards</surname><given-names>SW</given-names></name><name><surname>Hancock</surname><given-names>E</given-names></name><etal></etal></person-group>:
<article-title>Developmental and epilepsy outcomes at age 4 years in the UKISS trial comparing hormonal treatments to vigabatrin for infantile spasms: a multi-centre randomised trial.</article-title>
<source/><italic>Arch Dis Child.</italic>
<year>2010</year>;<volume>95</volume>(<issue>5</issue>):<fpage>382</fpage>–<lpage>6</lpage>.
<pub-id pub-id-type="doi">10.1136/adc.2009.160606</pub-id>
<pub-id pub-id-type="pmid">20457702</pub-id></mixed-citation>
</ref>
<ref id="ref-55">
<label>55</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bartolomei</surname><given-names>F</given-names></name><name><surname>Bettus</surname><given-names>G</given-names></name><name><surname>Stam</surname><given-names>CJ</given-names></name><etal></etal></person-group>:
<article-title>Interictal network properties in mesial temporal lobe epilepsy: a graph theoretical study from intracerebral recordings.</article-title>
<source/><italic>Clin Neurophysiol.</italic>
<year>2013</year>;<volume>124</volume>(<issue>12</issue>):<fpage>2345</fpage>–<lpage>53</lpage>.
<pub-id pub-id-type="doi">10.1016/j.clinph.2013.06.003</pub-id>
<pub-id pub-id-type="pmid">23810635</pub-id></mixed-citation>
</ref>
<ref id="ref-56">
<label>56</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bartolomei</surname><given-names>F</given-names></name><name><surname>Wendling</surname><given-names>F</given-names></name><name><surname>Bellanger</surname><given-names>JJ</given-names></name><etal></etal></person-group>:
<article-title>Neural networks involving the medial temporal structures in temporal lobe epilepsy.</article-title>
<source/><italic>Clin Neurophysiol.</italic>
<year>2001</year>;<volume>112</volume>(<issue>9</issue>):<fpage>1746</fpage>–<lpage>60</lpage>.
<pub-id pub-id-type="doi">10.1016/S1388-2457(01)00591-0</pub-id>
<pub-id pub-id-type="pmid">11514258</pub-id></mixed-citation>
</ref>
<ref id="ref-57">
<label>57</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bartolomei</surname><given-names>F</given-names></name><name><surname>Wendling</surname><given-names>F</given-names></name><name><surname>Régis</surname><given-names>J</given-names></name><etal></etal></person-group>:
<article-title>Pre-ictal synchronicity in limbic networks of mesial temporal lobe epilepsy.</article-title>
<source/><italic>Epilepsy Res.</italic>
<year>2004</year>;<volume>61</volume>(<issue>1–3</issue>):<fpage>89</fpage>–<lpage>104</lpage>.
<pub-id pub-id-type="doi">10.1016/j.eplepsyres.2004.06.006</pub-id>
<pub-id pub-id-type="pmid">15451011</pub-id></mixed-citation>
</ref>
<ref id="ref-58">
<label>58</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Spencer</surname><given-names>SS</given-names></name></person-group>:
<article-title>Neural networks in human epilepsy: evidence of and implications for treatment.</article-title>
<source/><italic>Epilepsia.</italic>
<year>2002</year>;<volume>43</volume>(<issue>3</issue>):<fpage>219</fpage>–<lpage>27</lpage>.
<pub-id pub-id-type="doi">10.1046/j.1528-1157.2002.26901.x</pub-id>
<pub-id pub-id-type="pmid">11906505</pub-id></mixed-citation>
</ref>
<ref id="ref-59">
<label>59</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Bertram</surname><given-names>EH</given-names></name><name><surname>Zhang</surname><given-names>DX</given-names></name><name><surname>Mangan</surname><given-names>P</given-names></name><etal></etal></person-group>:
<article-title>Functional anatomy of limbic epilepsy: a proposal for central synchronization of a diffusely hyperexcitable network.</article-title>
<source/><italic>Epilepsy Res.</italic>
<year>1998</year>;<volume>32</volume>(<issue>1–2</issue>):<fpage>194</fpage>–<lpage>205</lpage>.
<pub-id pub-id-type="doi">10.1016/S0920-1211(98)00051-5</pub-id>
<pub-id pub-id-type="pmid">9761320</pub-id></mixed-citation>
</ref>
<ref id="ref-60">
<label>60</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Shafi</surname><given-names>MM</given-names></name><name><surname>Vernet</surname><given-names>M</given-names></name><name><surname>Klooster</surname><given-names>D</given-names></name><etal></etal></person-group>:
<article-title>Physiological consequences of abnormal connectivity in a developmental epilepsy.</article-title>
<source/><italic>Ann Neurol.</italic>
<year>2015</year>;<volume>77</volume>(<issue>3</issue>):<fpage>487</fpage>–<lpage>503</lpage>.
<pub-id pub-id-type="doi">10.1002/ana.24343</pub-id>
<!--<pub-id pub-id-type="pmcid">4394240</pub-id>-->
<pub-id pub-id-type="pmid">25858773</pub-id></mixed-citation>
</ref>
<ref id="ref-61">
<label>61</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Lee</surname><given-names>HW</given-names></name><name><surname>Arora</surname><given-names>J</given-names></name><name><surname>Papademetris</surname><given-names>X</given-names></name><etal></etal></person-group>:
<article-title>Altered functional connectivity in seizure onset zones revealed by fMRI intrinsic connectivity.</article-title>
<source/><italic>Neurology.</italic>
<year>2014</year>;<volume>83</volume>(<issue>24</issue>):<fpage>2269</fpage>–<lpage>77</lpage>.
<pub-id pub-id-type="doi">10.1212/WNL.0000000000001068</pub-id>
<!--<pub-id pub-id-type="pmcid">4277677</pub-id>-->
<pub-id pub-id-type="pmid">25391304</pub-id></mixed-citation>
</ref>
<ref id="ref-62">
<label>62</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Morgan</surname><given-names>VL</given-names></name><name><surname>Abou-Khalil</surname><given-names>B</given-names></name><name><surname>Rogers</surname><given-names>BP</given-names></name></person-group>:
<article-title>Evolution of functional connectivity of brain networks and their dynamic interaction in temporal lobe epilepsy.</article-title>
<source/><italic>Brain Connect.</italic>
<year>2015</year>;<volume>5</volume>(<issue>1</issue>):<fpage>35</fpage>–<lpage>44</lpage>.
<pub-id pub-id-type="doi">10.1089/brain.2014.0251</pub-id>
<!--<pub-id pub-id-type="pmcid">4313394</pub-id>-->
<pub-id pub-id-type="pmid">24901036</pub-id></mixed-citation>
</ref>
<ref id="ref-63">
<label>63</label>
<mixed-citation publication-type="journal">
<person-group person-group-type="author"><name><surname>Vega-Zelaya</surname><given-names>L</given-names></name><name><surname>Pastor</surname><given-names>J</given-names></name><name><surname>de Sola</surname><given-names>RG</given-names></name><etal></etal></person-group>:
<article-title>Disrupted Ipsilateral Network Connectivity in Temporal Lobe Epilepsy.</article-title>
<source/><italic>PLoS One.</italic>
<year>2015</year>;<volume>10</volume>(<issue>10</issue>):<fpage>e0140859</fpage>.
<pub-id pub-id-type="doi">10.1371/journal.pone.0140859</pub-id>
<!--<pub-id pub-id-type="pmcid">4619301</pub-id>-->
<pub-id pub-id-type="pmid">26489091</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>